收稿日期: 2023-06-21
网络出版日期: 2024-03-06
基金资助
国家自然科学基金项目(82060139);浙江省中医药科技计划项目(2023ZL467)
Mechanism of iron death induced by high homocysteine via TRPC6/NF⁃κb in glomerular podiatocytes
Received date: 2023-06-21
Online published: 2024-03-06
目的 探讨TRPC6/NF?κB在高同型半胱氨酸（Hcy）介导下诱导肾小球足细胞铁死亡的机制。 方法 对小鼠肾脏足细胞进行体外培养，将其分成对照组（0 μmol/LHcy）和Hcy组（80 μmol/LHcy），干预细胞48 h后，采用Western blot检测GPX4、SLC7A11铁死亡相关蛋白以及TRPC6、NFκb蛋白表达情况；实时荧光定量PCR（qRT-PCR）与免疫荧光检测TRPC6的表达水平；通过流式细胞术检测足细胞凋亡率；采用丙二醛（MDA）试剂盒测定细胞内MDA活性水平。转染TRPC6干扰片段及TRPC6阴性对照（NC）后qRT-PCR分组为Control、si-NC及si-TRPC6（si-TRPC6-1、si-TRPC6-2、si-TRPC6-3），Western blot分组为Control、Hcy、si-NC+Hcy、si-TRPC6+Hcy，采用qRT-PCR检测TRPC6 mRNA的表达；采用Western blot检测GPX4、SLC7A11、NF-κb及TRPC6的表达水平；采用流式细胞术检测干扰后足细胞凋亡水平。 结果 （1）与Control组相比，Hcy组中铁死亡相关蛋白GPX4、SLC7A11表达水平减低，凋亡水平增加（P < 0.05）；（2）与Control组相比，Hcy组TRPC6蛋白、mRNA水平及免疫荧光表达均增加，MDA水平增高，NF-κb信号通路蛋白表达增加，两组间比较均差异有统计学意义（P < 0.05）；（3）与si-NC组相对比，si-TRPC6（si-TRPC6-1、si-TRPC6-2、si-TRPC6-3）组中TRPC6的mRNA表达水平降低，其中si-TRPC6-3干扰效果最佳（P < 0.05）；转染 TRPC6 NC 与 TRPC6 干扰片段并给予Hcy干预后，与Hcy组相比，si-NC+Hcy 组 GPX4、SLC7A11、NFκb、TRPC6表达无差异；与si-NC+Hcy 组相比，si-TRPC6+Hcy组中铁死亡相关蛋白：GPX4、SLC7A11表达增高，NFκb、TRPC6表达降低，凋亡率降低（P < 0.05）。 结论 本研究证实了在Hcy作用下TRPC6/NFκb可以调控肾足细胞铁死亡，是导致肾损伤的机制之一。
李小琴 , 汪乐新 , 马小军 , 李娜 , 卢冠军 , 张智涵 , 张鹏程 . 高同型半胱氨酸经TRPC6/NF⁃κB诱导肾小球足细胞铁死亡的机制[J]. 实用医学杂志, 2024 , 40(2) : 174 -181 . DOI: 10.3969/j.issn.1006-5725.2024.02.009
Objective To investigate the mechanism of iron death induced by TRPC6/NF?κB in glomerular podiocytes mediated by high homocysteine （Hcy）. Methods Mouse glomerulopocytes were cultured in vitro and divided into Control group （0 μmol/L Hcy） and Hcy group （80 μmol/L Hcy）. After 48h of intervention， Western blot was used to detect the expression levels of iron death related proteins GPX4 and SLC7A11 and TRPC6 and NF?κB. Real-time quantitative fluorescence PCR（qRT-PCR） and immunofluorescence were used to detect the expression of TRPC6. The level of podocyte apoptosis was detected by flow cytometry. Malondialdehyde （MDA） assay kit was used to determine intracellular MDA levels. After transfection of TRPC6 interference fragment and TRPC6 negative control （NC）， qRT-PCR was divided into Control， si-NC and si-TRPC6 （Si-TRPC6-1， Si-TRPC6-2， Si-TRPC6-3）. Western Blot was divided into Control， Hcy， si-NC+Hcy， si-TRPC6+Hcy.The expression of TRPC6 mRNA was detected by qRT-PCR. The expression levels of GPX4， SLC7A11， NF?κB and TRPC6 were detected by Western Blot. The level of podocyte apoptosis after interference was detected by flow cytometry. Results （1）Compared with Control group， the expression levels of iron death related proteins GPX4 and SLC7A11 in Hcy group were decreased， and the apoptosis rate was increased（P < 0.05）. （2） Compared with Control group， TRPC6 protein， mRNA levels and immunofluorescence expression were increased in Hcy group.The level of MDA and the expression of NF?κB signaling pathway protein increased in Hcy group， and the comparison between the two groups had statistical significance （P < 0.05）. （3） Compared with the si-NC group， the mRNA expression level of TRPC6 in si-TRPC6 （Si-TRPC6-1， Si-TRPC6-2， Si-TRPC6-3） group was decreased， and the interference effect of Si-TRPC6-3 was the best（P < 0.05）. After transfecting TRPC6 NC and TRPC6 interference fragment and administering Hcy， there was no difference in GPX4， SLC7A11， NF?κB and TRPC6 expression in si-NC+Hcy group compared with Hcy group. Compared with the si-NC+Hcy group， the si-TRPC6+Hcy group had higher expression of iron death related proteins， GPX4 and SLC7A11， lower expression of NF?κB and TRPC6， and decreased apoptosis rate（P < 0.05）. Conclusion This study confirmed that TRPC6/NF?κB can regulate iron death of renal podocytes under the induction of Hcy， which is one of the mechanisms leading to kidney injury.
Key words： iron death; TRPC6; NF?κB; kidney disease; high homocysteine
| 1 | KOVESDY C P. Epidemiology of chronic kidney disease： an update 2022［J］. Kidney Int Suppl， 2022，12（1）：7-11. doi:10.1016/j.kisu.2021.11.003 |
| 2 | LV J C， ZHANG L X.Prevalence and Disease Burden of Chronic Kidney Disease［J］. Adv Exp Med Biol， 2019， 1165（3）： 3-15. |
| 3 | SONG J H， HUH H， BAE E， et al. Association between homocysteinemia and mortality in CKD： A propensity-score matched analysis using NHANES-National Death Index［J］. Medicine （Baltimore）， 2022，101（36）：e30334. doi:10.1097/md.0000000000030334 |
| 4 | BADRI S， VAHDAT S， SEIRAFIAN S， et al. Homocysteine-Lowering Interventions in Chronic Kidney Disease［J］. J Res Pharm Pract， 2021，10（3）：114-124. doi:10.4103/jrpp.jrpp_75_21 |
| 5 | CHEN C， YANG W， HSIAO Y， et al. High homocysteine， low vitamin B-6， and increased oxidative stress are independently associated with the risk of chronic kidney disease［J］. Nutrition， 2016， 32：236-241. doi:10.1016/j.nut.2015.08.016 |
| 6 | 揭育祯，丁宁，谢琳，等. 同型半胱氨酸上调miR-488-3p表达诱导MPC-5小鼠肾小球足细胞凋亡［J］. 细胞与分子免疫学杂志，2022，38（9）：801-806. |
| 7 | 吴凯，刘昆，谢琳，等. 高同型半胱氨酸血症诱导Cbs~（+/-）小鼠肾损伤的作用机制［J］. 中国组织工程研究，2021，25（11）：1728-1732. |
| 8 | PALYGIN O. The role of TRPC6 channel in chronic kidney diseasel［J］. Am J Physiol Renal Physio， 2022，322（2）：F195-F196. doi:10.1152/ajprenal.00455.2021 |
| 9 | STARUSCHENKO A， MA R， PALYGIN O， et al. Ion channels and channelopathies in glomeruli［J］. Physiol Rev， 2023， 103（1）： 787-854. doi:10.1152/physrev.00013.2022 |
| 10 | KIM E Y， DRYER S E.TRPC6 Inactivation Reduces Albuminuria Induced by Protein Overload in Sprague Dawley Rats［J］.Cells， 2022， 11（13）： 1985-1986. doi:10.3390/cells11131985 |
| 11 | DRYER S E， KIM E Y. The Effects of TRPC6 Knockout in Animal Models of Kidney Disease［J］. Biomolecules， 2022，12（11）：1710. doi:10.3390/biom12111710 |
| 12 | HOU X， XIAO H， ZHANG Y， et al. Transient receptor potential channel 6 knockdown prevents apoptosis of renal tubular epithelial cells upon oxidative stress via autophagy activation［J］.Cell Death Dis， 2018， 9（10）：1015-1033. doi:10.1038/s41419-018-1052-5 |
| 13 | STOCKWELL B R. Ferroptosis turns 10： Emerging mechanisms， physiological functions， and therapeutic applications［J］. Cell， 2022，185（14）：2401-2421. doi:10.1016/j.cell.2022.06.003 |
| 14 | ZHANG X， HUANG Z， XIE Z， et al. Homocysteine induces oxidative stress and ferroptosis of nucleus pulposus via enhancing methylation of GPX4［J］. Free Radic Biol Med， 2020，160： 552-565. doi:10.1016/j.freeradbiomed.2020.08.029 |
| 15 | LANG X， GREEN M D， WANG W， et al. Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11［J］. Cancer Discov，2020，9（12）：1673-1685. doi:10.1158/2159-8290.cd-19-0338 |
| 16 | KARMIN O， SIOW Y L. Metabolic Imbalance of Homocysteine and Hydrogen Sulfide in Kidney Disease［J］. Curr Med Chem， 2020， 25（3）： 367-377. |
| 17 | 程小兵，罗娟娟，陈燕，等. 小而密低密度脂蛋白胆固醇及其与低密度脂蛋白胆固醇之比、同型半胱氨酸对颈动脉粥样硬化的影响［J］. 实用医学杂志，2020，36（19）：2684-2689. |
| 18 | YUAN S， MASON A， CARTER P， et al. Homocysteine， B vitamins， and cardiovascular disease： a Mendelian randomization study［J］. BMC Med， 2021， 19（1）： 97-108. doi:10.1186/s12916-021-01977-8 |
| 19 | GOSPODARCZYK A， MARCZEWSKI K， GOSPODARCZYK N， et al. HOMOCYSTEINE AND CARDIOVASCULAR DISEASE-A CURRENT REVIEW［J］. Wiad Lek，2022，75（11pt2）：2862-2866. doi:10.36740/wlek202211224 |
| 20 | BADRI S， VAHDAT S， SEIRAFIAN S，et al. Homocysteine-Lowering Interventions in Chronic Kidney Disease［J］. J Res Pharm Pract， 2021，10（3）：114-124. doi:10.4103/jrpp.jrpp_75_21 |
| 21 | ZHANG C， BOINI K M， XIA M， et al. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia［J］. Hypertension，2020，60（1）：154-162. |
| 22 | LIANG S， LIU H， LIU S， et al. viaHomocysteine induces human mesangial cell apoptosis the involvement of autophagy and endoplasmic reticulum stress［J］. RSC Adv，2019，9（54）：31720-31727. doi:10.1039/c9ra04248b |
| 23 | CHEN X， YU C， KANG R， et al. Cellular degradation systems in ferroptosis［J］. Cell Death Differ， 2021，28（4）：1135-1148. doi:10.1038/s41418-020-00728-1 |
| 24 | HALL G， WANG L， SPURNEY R F. TRPC Channels in Proteinuric Kidney Diseases［J］. Cells，2019，9（1）：44-57. doi:10.3390/cells9010044 |
| 25 | REISER J， POLU K R， M?LLER C C， et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function［J］. Nat Genet， 2005， 37（7）：739-744. doi:10.1038/ng1592 |
| 26 | FENG Y， LI M， WANG Y， et al. Activation of TRPC6 by AngⅡ Induces Podocyte Injury and Participates in Proteinuria of Nephrotic Syndrome［J］. Front Pharmacol，2022，13：915153. doi:10.3389/fphar.2022.915153 |
| 27 | GRAHAM S， DING M， DING Y， et al. Canonical transient receptor potential 6 （TRPC6）， a redox-regulated cation channel［J］. J Biol Chem， 2020，285（30）：23466-23476. |
| 28 | MA R， CHAUDHARI S， LI W. Canonical Transient Receptor Potential 6 Channel： A New Target of Reactive Oxygen Species in Renal Physiology and Pathology［J］. Antioxid Redox Signal， 2016，25（13）：732-748. doi:10.1089/ars.2016.6661 |
| 29 | MA M， ZHAO S， ZHANG J， et al. High Glucose-Induced TRPC6 Channel Activation Decreases Glutamate Uptake in Rat Retinal Müller Cells［J］. Front Pharmacol， 2020，10（undefined）：1668. doi:10.3389/fphar.2019.01668 |
| 30 | WANG Z， WEI X， ZHANG Y， et al. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury［J］. Cell Physiol Biochem， 2019，24（5-6）：619-626. |
| 31 | CHEN X L M， HE X， MA L， et al. TRPC3/6/7 Knockdown Protects the Brain from Cerebral Ischemia Injury via Astrocyte Apoptosis Inhibition and Effects on NFκB Translocation［J］. Mol Neurobiol， 2017，254（10）：7555-7566. doi:10.1007/s12035-016-0227-2 |
| 32 | 邓林林，张啸，高仪，等. miR-216a调控NF-κB信号通路参与脓毒症急性肾损伤的机制［J］. 实用医学杂志，2022，38（17）：2133-2137. doi:10.3969/j.issn.1006-5725.2022.17.004 |
/
| 〈 |
|
〉 |